Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    

ARENA PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about ARENA PHARMACEUTICALS, INC
05/21ARENA PHARMACEUTICALS : Announces Data Presentation for Ralinepag in Pulmonary A..
PU
05/17ARENA PHARMACEUTICALS : to Present at Upcoming Investor Conferences
AQ
05/15ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2018..
AQ
05/10ARENA PHARMACEUTICALS : to Present at Upcoming Investor Conferences
PR
05/08ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2018..
PR
05/07ARENA PHARMACEUTICALS : to Release First Quarter 2018 Financial Results and Prov..
AQ
05/07ARENA PHARMACEUTICALS : and Outpost Medicine Enter into Licensing Agreement for ..
AQ
05/02ARENA PHARMACEUTICALS : to Release First Quarter 2018 Financial Results and Prov..
PR
05/01ARENA PHARMACEUTICALS : and Outpost Medicine Enter into Licensing Agreement for ..
PR
04/17ARENA PHARMACEUTICALS : Announces Phase 2 Data Presentation for Ralinepag in Pul..
AQ
04/12ARENA PHARMACEUTICALS : Announces Phase 2 Data Presentation for Ralinepag in Pul..
PR
03/29ARENA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stock ..
AQ
03/26ARENA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stock ..
PR
03/26ARENA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
AQ
03/24ARENA PHARMACEUTICALS : to Present at the 17th Annual Needham Healthcare Confere..
PR
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
05/21ARENA PHARMACEUTICALS : Announces Data Presentation for Ralinepag in Pulmonary A..
PU
05/17ARENA PHARMACEUTICALS : to Present at Upcoming Investor Conferences
AQ
05/15ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2018..
AQ
05/11ARENA PHARMACEUTICALS : and Outpost Medicine Enter into Licensing Agreement for ..
AQ
05/10ARENA PHARMACEUTICALS : and Outpost Medicine Enter into Licensing Agreement for ..
AQ
05/10ARENA PHARMACEUTICALS : to Present at Upcoming Investor Conferences
PR
05/09ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
AQ
05/08ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Finan..
AQ
05/08ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2018..
PR
05/07ARENA PHARMACEUTICALS : to Release First Quarter 2018 Financial Results and Prov..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
05/25The Heated Quest for Opioid Alternatives -2-
DJ
05/25The Heated Quest for Opioid Alternatives
DJ
05/18GLAXOSMITHKLINE : Regulators flag possible birth defect link to GSK's HIV drug
RE
05/11Trump's Plan to Cut Drug Prices Leaves Industry Relieved
DJ
05/09Drugmaker GSK rings in more change as CFO heads for exit in 2019
RE
05/08UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2017Arena Pharmaceuticals (ARNA) Presents At JMP Securities Life Sciences Confere.. 
2017Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at JMP Securities Life.. 
2017Arena continues up move, shares ahead 25% in three days 
2017DRYSHIPS : Rank #1 As Worst Stock In Nasdaq 
2017Stocks to watch next week 
2017PREMARKET LOSERS AS OF 9 : 05 am 
Financials ($)
Sales 2018 9,23 M
EBIT 2018 -136 M
Net income 2018 -140 M
Finance 2018 176 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 223x
EV / Sales 2019 206x
Capitalization 2 231 M
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | US0400471027 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 61,5 $
Spread / Average Target 36%
EPS Revisions
Managers
NameTitle
Amit Dilip Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
Preston S. Klassen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS, INC.14.01%2 231
CELLTRION, INC.--.--%32 036
IQVIA HOLDINGS INC4.64%20 818
LONZA GROUP1.63%20 226
INCYTE CORPORATION-29.71%14 505
NEKTAR THERAPEUTICS42.83%13 705